News

We want to know: Will you be attending the conference in Seattle this week?

This review of the latest dermatologic studies includes insights into pruritus as an indicator for QoL in CTCL, the research landscape of acquired dermal macular hyperpigmentation, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Updated research finds that chronic stress disrupts healing processes and scar treatments, limiting the effectiveness of wound care in some patients.

Lars French, MD, explains how the new WHA resolution on skin health could drive training, access, and global policy change.

A new WHA resolution spotlights skin health, pushing member states to close care gaps and integrate dermatology into public health.

Sun Pharma reveals promising phase 3 results for tildrakizumab (Ilumya) in treating PsA, showing significant symptom improvement in patients.

Matthew Zirwas, MD, discusses the complexities of safety analysis in psoriasis clinical trials, advocating for exposure-adjusted incidence rates to enhance risk communication.

Social media spreads significant retinol misinformation, risking adolescent skin health. Experts call for improved digital education and accurate content creation.

Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.

Topical ruxolitinib, phototherapy, and psychosocial care took center stage in an interactive discussion between Seemal Desai, MD, FAAD, and colleagues, on managing complex vitiligo cases.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At a recent Dermatology Times Case-Based Roundtable event, Stephanie Simmerman, DNP, APRN-C, discussed treatment selection, access challenges, and more for patients with vitiligo.

According to new research from Steven Dayan, MD, FACS, PROs are reshaping aesthetic medicine, enhancing Botox treatment insights and prioritizing holistic patient care.

Bristol Myers Squibb's deucravacitinib gains global regulatory acceptance for treating active psoriatic arthritis, promising a new oral treatment option.

The 2025 Fall Clinical Dermatology Conference energized PAs and NPs with innovative strategies, addressing burnout, digital branding, and personalized medicine.

Johnson & Johnson submitted an NDA for icotrokinra, a promising new treatment for moderate to severe plaque psoriasis in adults and adolescents.

A retrospective case series found that apremilast induced complete remission in 6 men with treatment-resistant genital psoriasis.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the launch of deuruxolitinib for alopecia areata, Treg cel impairment in vitiligo, the top aesthetic innovations of this month, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research highlights the significant impact of dermatological diseases on work-life balance, revealing greater burdens for women compared to men.

The dermatology community mourns the loss of Dr. Robert Sidbury, a visionary leader in pediatric dermatology, whose impact and mentorship resonate deeply.

Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.

Global acne burden in reproductive-age women has risen significantly, with greater increases expected by 2040.

Experts share how this year's RAD Conference showcased cutting-edge advancements in atopic dermatitis to enhance patient care and treatment strategies.

Hershel Dobkin, MD, FAAD, shares his experiences and the surprising reasons behind clinic delays, from patient needs to unexpected moments.